目的:采用小鼠成肌细胞C2C12作为模型,观察光生物调节作用对他汀类药物引起的肌病的作用。 方法:实验于2004-09/2005-01在华南师范大学激光运动医学实验室完成。C2C12细胞用浓度分别为2.0×10^-5, 2.0×10^-6, 2.0×10^-7 ,2.0×10^-8 mol/L的辛伐他汀培养,然后用强度分别为0,0.229,0.506,0.848,1.401,1.670mW/cm^2的红色发光二极管[波长(640±15)nm]照射2d,15min/d。用甲基噻唑基四唑比色法评价细胞增殖。 结果:浓度为2.0×10^-6, 2.0×10^-7 and 2.0×10^-8的辛伐他汀对C2C12的增殖没有影响,无光生物调节作用;浓度为2.0×10^-5 mol/L的辛伐他汀抑制C2C12的增殖,发光二极管强度为0,0.229,0.506,0.848,1.401,1.670mW/cm^2时C2C12细胞增殖吸光度百分率分别降为(37.2±84)%,(58.4±94.9)%,(37.0±8.6)%,(63.0±8.8)%,(59.2±12.6)%,(28.9±90.3)%。强度为0.848mW/cm^2的红色发光二极管照射2d,15min/d可促进被抑制的C2C12增殖效应。 结论:红色发光二极管可以促进被辛伐他汀抑制的C2C12细胞的增殖作用,对服用他汀类药物引起的肌病可能有光生物调节作用。
AIM: To use the mouse myoblast line, C2C12, as an in vitro model to observe the effect of photobiomodulation on statin induced myopathy. METHODS: The experiment was carried out at the Laboratory of Laser Sports Medicine, South China Normal University, between September 2004 and January 2005. C2C12 cells were cultured with simvastatin at 2.0×10^-5, 2.0×10^-6, 2.0×10^-7 and 2.0×10^-8 mol/L and irradiated by red light emitting diode (RLED) [640±15 nm in wave length] at 0, 0.229, 0.506, 0.848, 1.401 and 1.670 mW/cm^2 separately for 15 minutes per day, 2 days in total. The cellular proliferation was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyl tetrazolium bromide (MTT). RESULTS: Simvastatin at 2.0×10^-6, 2.0×10^-7 and 2.0×10^-8 mol/L did not inhibit C2C12 cellular proliferation, and no photobiomodulation was found. However, simvastatin at 2 ×10^ -5 mol/L inhibited C2C12 cellular proliferation . When the intensity of RLED was 0,0.229,0.506,0.848, 1.401,1.670 mW/cm^2, the absorbance of C2C12 cellular proliferation was (37.2±8.4)%, (58.4±24.9)%, (37.0±8.6)%, (63.0±8.8)%, (59.2±12.6)%, (28.9±20.3)%, respectively . The inhibited C2C12 proliferation was promoted with RLED irradiation at 0.848 mW/cm^2 for 15 minutes per day, 2 days in total. CONCLUSION: RLED can promote the proliferation of C2C12 inhibited by statin, which indicates that RLED might .has photobiomodilative effect on statin induced myopathy.